
While Nvidia (NVDA) and its Big Tech peers have driven the S&P 500 Index ($SPX) to new all-time highs this year, several other growth stocks across multiple sectors are flying under the radar. One of these names is biotech stock Viking Therapeutics (VKTX), which has returned 283% so far in 2024, and is up 520% in the last 12 months.
Valued at a market cap of $7.43 billion, the mid-cap pharmaceutical company also trades 28% below its February all-time highs, after losing close to 19% in a single trading session this Thursday.